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We have investigated eﬀect of Moringa oleifera leaf and fruit extracts on markers of oxidative stress, its toxicity evaluation, and
correlation with antioxidant properties using in vitro and in vitro assays. The aqueous extract of leaf was able to increase the GSH
and reduce MDA level in a concentration-dependent manner. The ethanolic extract of fruit showed highest phenolic content,
strong reducing power and free radical scavenging capacity. The antioxidant capacity of ethanolic extract of both fruit and leaf was
higher in the in vitro assay compared to aqueous extract which showed higher potential in vivo. Safety evaluation studies showed
no toxicity of the extracts up to a dose of 100mg/kg body weight. Our results support the potent antioxidant activity of aqueous
and ethanolic extract of Moringa oleifera which adds one more positive attribute to its known pharmacological importance.
1.Introduction
Moringa oleifera Lam (syn. M. pterygosperma; commonly
knownas“TheMiracleTree,”“Horseradish-tree,”or“Benoil
tree”) is the best known and most widely distributed species
of Moringaceae family, having an impressive range of medic-
inal uses with high nutritional value throughout the world.
Native to Western and sub-Himalayan tracts, India, Pakistan,
Asia, and Africa [1, 2], this plant is well distributed in the
Philippines, Cambodia, America, and the Caribbean Islands
[3]. Organizations such as Trees for Life, Church World
Service, and Educational Concerns for Hunger Organization
have advocated Moringa as “Natural Nutrition for the
Tropics” in various parts of the world [4–11]. Almost every
part of this highly esteemed tree have long been consumed
by humans and used for various domestic purposes as for
alley cropping, animal forage, biogas, domestic cleaning
agent, blue dye, fertilizer, foliar nutrient, green manure,
gum (from tree trunks), honey and sugar cane juice-clariﬁer
(powdered seeds), ornamental plantings, biopesticide, pulp,
rope, tannin for tanning hides, water puriﬁcation, machine
lubrication (oil), manufacture of perfume, and hair care
products [6].
Besides culinary and other domestic uses, several biolog-
ical properties ascribed to various parts of this tree have been
reviewed in the past [10, 12]. The leaves of M. oleifera have
been reported to be a valuable source of both macro- and
micronutrients, rich source of β-carotene, protein, vitamin
C, calcium, and potassium and act as a good source of
natural antioxidants; and thus enhance the shelf-life of fat-
containing foods [7, 13]. Fruit (pod)/drum sticks and leaves
have been used to combat malnutrition, especially among
infants and nursing mothers for enhancing milk production
[7, 14] and also regulate thyroid hormone imbalance [15–
17].
A number of medicinal properties attributed to diﬀerent
parts of Moringa have been recognized by both Ayurvedic
and Unani systems of medicines [2]. The plant ﬁnds its wide
applicability in the treatment of cardiovascular diseases as
the roots, leaves, gum, ﬂowers, and infusion of seeds have
nitrile, mustard oil glycosides, and thiocarbamate glycosides
as their chemical constituents which are suggested to be2 Evidence-Based Complementary and Alternative Medicine
responsible for the diuretic, cholesterol lowering, antiulcer,
hepatoprotective, and cardiovascular protective property of
the tree [10, 15, 16, 18–28]. The roots have been reported
to possess antispasmodic activity through calcium channel
blockade which forms the basis for its traditional use in
diarrhoea[20,29].Italsopossessesantimicrobialactivitydue
to its principle component pterygospermin. The fresh leaf
juice was found to inhibit the growth of human pathogens
as Staphylococcus aureus and Pseudomonas aeruginosa [30–
33]. Phytoconstituents from diﬀerent parts of the tree as
niazimicin, niaiminin, various carbamates, and thiocarba-
mates (Table 1 Supplementry materials available at doi:
10.1155/2012/519048) have shown to exhibit antitumor
activity in vitro [34–36] .T h eﬂ o w e r ss h o we ﬀective hepato-
protective eﬀect due to the presence of quercetin [29–37].
Seeds are used as biosorbent for the removal of cadmium
from aqueous medium and are one of the best-known
natural coagulants discovered so far [38, 39]. They are also
considered to be antipyretic, acrid, and bitter and reported
to show antimicrobial activity [40, 41].
Various parts of the plant and their active constituents
are known to possess diverse biological activity, however,
little is known scientiﬁcally about the antioxidant potential
of fruit (pod) and leaves of Moringa oleifera. Therefore,
the present study investigates, establishes, and explains a
comparative analysis of concentration- and dose-dependent
eﬀect of ethanolic and aqueous extract of M. oleifera leaves
and fruit on markers of oxidative stress, its safety proﬁle
in mice model, and correlation with antioxidant properties
using in vitro and in vivo assays.
2.MaterialsandMethods
2.1.Chemicals. Allthechemicals,reagents,andsolventsused
in the assay protocols were of analytical grade. Ascorbic acid,
sodium phosphate, phosphate buﬀer saline, thiobarbituric
acid, ammonium molybdate, ethyldimine tetraacetic acid
(EDTA), sodium citrate, DPPH, DMSO, Folin-Ciocalteau
reagent, sodium acetate trihydrate, sodium hydroxide tricar-
boxylic acid, and sodium citrate were obtained from Sigma
Aldrich, India. Other chemicals such as gallic acid, TRIS-
HCl, sodium carbonate, sodium chloride, potassium ferri-
cynide, ferric chloride, tripyridyl-s-triazine (TPTZ), potas-
sium dihydrogen phosphate, disodium hydrogen phosphate,
metaphosphoric acid, and 5, 5 -Dithiobis 2-nitro benzoic
acid (DTNB) were purchased from Himedia, India. The
solvents, methanol, ethanol, glacial acetic acid, sulphuric
acid, hydrochloric acid, kits for determination of RBC,
WBCandhaemoglobin,activitykitsforalkalinePhosphatase
(ALKP), serum glutamic pyruvic transaminase (SGPT),
and serum glutamic oxaloacetic transaminase (SGOT) were
ordered from E-Merck Ltd., India.
2.2. Collection of Plant Material and Preparation of Extract.
T h el e a v e sa n df r u i t( p o d )o fMoringa oleifera Lam (syn.
M. pterygosperma) were collected from the research farm
of the Central Institute of Medicinal and Aromatic Plants
(CSIR), Lucknow, India, and the herbarium specimens were
deposited in Gyan Surabhi of CIMAP, Lucknow (Voucher
Specimenno.9076).PlantmaterialwasauthenticatedbyDrs.
A. K. Gupta, S. C. Singh, S. P. Jain, and J. Singh. The leaves
and fruit (pod) samples were washed properly and dried at
40◦C. The dried samples were extracted with 100% ethanol
and distilled water. The extracts were collected at least three
times and were ﬁltered through Whatman number 1 ﬁlter
paper and then concentrated on rotary evaporator (Buchi,
Flavil, Switzerland) at 45◦C, dried and kept at 4◦C till used
for the assay. The sample and solvent mass ratio was 1:2
during extraction. The extracts were dissolved/solubilised
in DMSO and diluted with sterile water to get the ﬁnal
concentration as per requirement.
2.3. Selection of Animals and Dose Administration. In view
of potent antioxidant activity of M. oleifera aqueous and
ethanolic extracts in in vitro model, acute oral toxicity of
the same was carried out in Swiss albino mice for its further
development into drug product. Experiment was conducted
in accordance with the Organization for Economic Co-
operation and Development (OECD) test guideline number
423 (1987).
For the study, 24 mice were taken and divided into
six groups comprising male mice in each group weighing
between 25 and 30g. The animals were maintained at 22 ±
5◦C with humidity control and also on an automatic dark
and light cycle of 12 hours. The animals were fed with the
standard rat feed and provided ad libitum drinking water.
Mice of group 1 were kept as control and animals of groups
2, 3, 4, 5, and 6 were kept as experimental. The animals were
acclimatized for 7 days in the experimental environment
prior to the actual experimentation. The test extracts were
given at 0.01, 0.1, 1, 10, and 100mg/kg body weight to
a n i m a l so fg r o u p s2 ,3 ,4 ,5 ,a n d6 ,r e s p e c t i v e l y .C o n t r o l
animals received only vehicle. All the animals were sacriﬁced
on the seventh day after the experimentation.
2.4. Collection of Blood and Serum and Isolation of Packed
Erythrocytes. Retino-orbital blood from healthy mice (Mus
musculus) was collected for experiments using Heparin
(10units/mL) as the anticoagulant from all the animals on
the seventh day after experiment. The collected blood was
storedat4◦Candwasusedforexperimentswithinfourhours
of collection. The serum samples were stored at −20◦Ca n d
were used within 2 days of collection [42–44]. The blood
samples were centrifuged at 4◦C for 10min at 3000rpm to
remove plasma and buﬀy coat. The isolated erythrocytes
were washed with 0.154mol/L normal saline (NaCl) thrice
for packed erythrocytes.
2.5. In Vitro Experiments
2.5.1. Total Phenolic Estimation. The total phenolic content
of the aqueous and ethanolic extract of M. oleifera was esti-
mated in terms of gallic acid equivalence by Folin-Ciocalteau
reagent by the method of Singleton and Rossi [45], with
slight modiﬁcation [46]. The Folin-Ciocalteau assay relies
on the transfer of electrons in alkaline medium from
phenolic compounds to phosphomolybdic/phosphotungstic
acid complexes, which are determined spectroscopically atEvidence-Based Complementary and Alternative Medicine 3
765nm. Diﬀerent concentration of aqueous and ethanolic
extracts of M. oliefera extracts (10, 50, 100, 250, 500, and
1000μg/mL) was mixed with Folin’s reagent (1:9 in distilled
water) and 7.5% Na2CO3 and incubated at 37◦C for 90min.
The absorbance was measured at 765nm.
2.5.2. Reducing Power Assay. The reducing power of the
aqueous and ethanolic extract of M. oleifera was determined
bythemethod ofYenandChen[47]withslightmodiﬁcation
reported previously [46]. Brieﬂy, for in vitro analyses,
diﬀerent concentrations of extract (10, 50, 100, 250, 500, and
1000μg/mL) was mixed with 0.2M phosphate buﬀer (pH
6.6) and 1% K4FeCN6 and incubated for 20min at 50◦C
followed by precipitation with 10% TCA. The supernatant
was diluted with equal volume of distilled water and ferric
reducing capacities of the extracts were checked by adding
0.10%FeCl3.Theabsorbancewasrecordedat700nmagainst
a reagent blank.
2.5.3. FRAP Assay. The ferric reducing antioxidant power
(FRAP) measures the antioxidant capacity to reduce the
Fe+++/tripyridyl-s-triazine (TPTZ) complex, to the ferrous
form [46, 48]. The FRAP reagent was freshly prepared
by mixing 10mM TPTZ with 20mM ferric chloride in
300mM acetate buﬀer, pH 3.6 in the ratio 1:1:10. Diﬀerent
concentrations (10, 50, 100, 250, 500, and 1000μg/mL) of
aqueous and ethanolic extract of M. oleifera were added and
the decrease in the absorption by the complex was measured
after 5min at 593nm at room temperature. The activities
were calculated by comparing the concentration of each
extract with the concentration of Fe++ required to give the
same absorbance change using FeSO4 as standard.
2.5.4. DPPH Assay. Radical scavenging activity of aqueous
and ethanolic extract of M. oleifera was measured by the
modiﬁed DPPH method [46, 49]. DPPH in ethanol is a
stable radical, dark violet in color. Its color is bleached by
its reaction with a hydrogen donor. For in vitro analyses,
variousconcentrationsofeachextracts(10,50,100,250,500,
and 1000μg/mL) were added to 100mM TRIS-HCl buﬀer
(pH 7.4) and 100μM of DPPH. The reaction mixture was
incubated for 30min in the dark at room temperature and
measured at 515nm, against a blank.
2.5.5. Total Antioxidant Capacity Estimation. The total
antioxidant capacity of M. oleifera was evaluated by the
method described in [50]. The total antioxidant capacity
of various concentrations of ethanolic and aqueous extracts
of M. oleifera (10, 50, 100, 250, 500, and 1000μg/mL) was
determined with phosphomolybdenum using ascorbic acid
as the standard in 1mL of TAC reagent (3.3mL sulphuric
acid, 335mg sodium phosphate, and 78.416mg ammonium
molybdate in 100mL of distilled water). The sample mix-
tures were incubated in a boiling water bath at 95◦Cf o r
90min. The absorbance of the samples was measured at
695nm. The blank solution contained 1.0mL of reagent
solutionandtheappropriatevolumeofthesamesolventused
for the sample.
2.6. In Vivo Experiments
2.6.1. Estimation of Reduced Glutathione Concentration. The
reduced glutathione concentration in erythrocytes was esti-
mated using standard method of Beutler [51], as reported
previously[44]withslightmodiﬁcation. To100μLo fpac k ed
RBC, 900μL of phosphate solution was added. Tubes were
centrifuged at 5000rpm for 5min and supernatant was
discarded. To 100μL of RBC (pellet), 100μL of phosphate
solution was added. Out of 200μL of cell suspension, to
100μL of it, 900μL of distilled water was added followed
by the addition of 1.5mL precipitation solution and tubes
were centrifuged at 5000rpm for 3min. To the 50μLo f
supernatant, 200μL phosphate solutions and 25μL of freshly
prepared DTNB were added. This method is based on
the ability of the sulfhydryl group to reduce 5,5 -Dithiobis
2-nitro benzoic acid (DTNB) and form a yellow-colored
anionic product whose absorbance is measured at 412nm.
Concentration of GSH is expressed as μmol/mL of packed
erythrocytes and was determined from a standard plot.
2.6.2.DeterminationofMalondialdehydeConcentration. Ery-
throcyte malondialdehyde formed during lipid peroxidation
was measured according to the method of Esterbauer and
Cheeseman [52], as described earlier [44]. Packed ery-
throcytes (200μL) were suspended in 3mL of PBS-glucose
solution (pH 7.4). To 1.0mL of the suspension, 1.0mL of
10% TCA was added. Centrifugation was done for 5min at
5000rpm. To 1.0mL of supernatant, 1.0mL of 0.67% TBA
in 0.05mol/L NaOH was added. Tubes were kept in boiling
water bath for 20min at temperature greater than 90◦Ca n d
cooled. Absorbance was measured at 532nm (OD1)a n d
600nm (OD2) against a blank. The net optical density (OD)
was calculated after subtracting absorbance at OD2 from
that of OD1. The concentration of MDA was determined
from a standard plot and expressed as nmol/mL of packed
erythrocytes.
2.6.3. Total Phenolic Estimation. The serum samples were
taken from 6 groups of mice administrated with diﬀerent
doses (0.01, 0.1, 1, 10, 100mg/kgb/w) of aqueous and
ethanolic extracts of M. oliefera, along with a control group
and was mixed with Folin’s reagent (1:9 in distilled water)
and 7.5% Na2CO3. Samples were incubated at 37◦Cf o r
90min. The absorbance was measured at 765nm against the
reference blank. The serum samples from mice administered
with gallic acid was used as the standard reference (Supple-
mentary material).
2.6.4. Reducing Power Assay. The reducing power of the
serum samples of mice administrated with diﬀerent doses
(0.01, 0.1, 1, 10, 100mg/kgb/w) of aqueous and ethanol
extracts of M. oliefera, along with a control were analyzed
by mixing serum, with 0.2M phosphate buﬀer (pH 6.6) and
1% K4FeCN6 and incubated for 20min at 50◦C followed by
precipitation with 10% TCA. The supernatant was diluted
with equal volume of distilled water and ferric reducing
capacities of the extracts were checked by adding 0.10%
FeCl3. The absorbance was recorded at 700nm against a
reagent blank.4 Evidence-Based Complementary and Alternative Medicine
2.6.5. FRAP Assay. The serum samples of all the six groups
of mice were added with FRAP reagent and the decrease in
the absorption by the complex was measured after 5min at
593nm at room temperature. The activities were calculated
by comparing the concentration of each extract with the
concentration of Fe++ required to give the same absorbance
change using FeSO4 as standard.
2.6.6. DPPH Assay. For in vivo analyses, serums of mice
mice administrated with diﬀerent doses (0.01, 0.1, 1, 10,
100mg/kgb/w) of aqueous and ethanolic extracts of M.
oliefera, were added to 100mM TRIS-HCl buﬀer (pH 7.4)
and 100μM of DPPH. The reaction mixture was incubated
for 30min in the dark at room temperature and measured
at 515nm, against a reference blank. Serum taken from mice
administered with Ascorbic acid and Gallic acid were used as
standard.
2.6.7. Total Antioxidant Capacity Estimation. The in vivo
analyses were performed by mixing serum samples from
mice of diﬀerent groups in 1mL of TAC reagent and
incubating the sample mixtures in a boiling water bath
at 95◦C for 90min. The absorbance of the samples was
measured at 695nm. The serum samples from mice admin-
istered with ascorbic acid was used as the standard reference
(Supplementary material).
2.7. Observational, Haematological, Biochemical, and Gross
Pathological Study. The animals were checked for mortality
and any sign of ill health at hourly interval on the day of
administration of drug and there after a daily general case
side clinical examination was carried out including changes
in skin, mucous membrane, eyes, occurrence of secretion
and excretion, and also responses like lachrymation, pilo-
erection respiratory patterns, and so forth. Also changes in
gait, posture, and response to handling were also recorded
[53]. In addition to observational study, body weights were
recorded and blood and serum samples were collected from
all the animals on the seventh day after experiment and were
analysed for total RBC, WBC, haemoglobin percentage, and
biochemical parameters like ALKP, SGPT and SGOT activity
using kits from E-Merck Ltd. in a semi-autoanalyser (RA-50)
made by Bayer Co Ltd., Germany [54].
2.8. Statistical Analysis. The data were subjected to two-
tailed Student’s “t” test with Welch correction and linear
regression analysis using Graph Pad InStat 3.06 Version. Val-
ues expressed are mean of three replicate determinations ±
standard deviation.
3. Result
A concentration- and dose-dependent in vitro and in vivo
evaluation of the oxidative stress biomarkers, toxicity mark-
ers, and its correlation with the antioxidative properties was
studied for the ethanolic and aqueous extracts of fruit and
leaves. Activity of extracts were tested by performing in
vitro and in vivo assays, namely: GSH, MDA, FRAP, DPPH,
T P C ,R P ,T A C ,S G P T ,S G O T ,A L K P ,H b ,W B C ,R B C ,a n d
body weight determination and observations are presented
in Figures 1–19.
3.1. In Vitro Analysis
3.1.1. Total Phenolic Content. Plant phenolics constitute
one of the major groups of compounds acting as primary
antioxidants or free radical terminators; it was worth deter-
mining their total amount (TPC) in the leaves and fruit
extract of M. oleifera. Total phenolic content increased in
the concentration-dependent manner having a gallic acid
equivalent of 22 ± 2μg/mL for all the extracts. But there
is signiﬁcant rise in the phenolic content of fruit ethanolic
(MFE) extract 53 ± 1.8μg/mL GAE (Figure 1). A signiﬁcant
pattern(P = 0.0053)wasobservedbothintheinvitrostudies
and in vivo analysis.
3.1.2. Reducing Power. The extracts showed an increasing
trend in reducing power as the concentration rises. The
extract MFE (P<0.0001) has the highest reducing power
capacity (Figure 2) among all the four extracts following the
trend MFE > MFW∼MLE > MLW.
3.1.3. DPPH. The scavenging activity of the DPPH radical
was tested by reduction of the stable radical DPPH to the
yellow-colored diphenylpicrylhydrazine. The experimental
observations of scavenging eﬀect of M. oleifera extracts with
the DPPH radical are depicted in Figure 3. In vitro analysis
r e v e a l st h a tf r u i te x t r a c t( M F E ∼MFW > MLE∼MLW) was
better scavengers than the leaves (P<0.001). With an
increase in the concentration, the scavenging potential of the
extracts increased by combating formation of the DPPH free
radical.
3.1.4. FRAP. Ferric reducing antioxidant power of the
extract of M. oleifera fruit and leaves was expressed as
equivalence of ferrous sulphate (μM/L) and our observation
depicts that the ferric reducing antioxidant power of the
extracts was in the increasing trend with the concentrations
(Figure 4). The observations of FRAP analysis also showed
a positive correlation with results of the reducing power
and DPPH radical scavenging analysis. The ethanolic extract
of fruit (MFE; P<0.0001) showed all the three activities
with highest eﬃciencies followed by the other three extracts
(MFW, MLE, and MLW).
3.1.5. Total Antioxidant Capacity. The total antioxidant
capacity of the extracts was determined in terms of ascorbic
acid equivalence, and our result suggests MLE (P<0.001)
exhibits the highest antioxidant capacity (MLE > MFE >
MFW > MLW). The antioxidant capacity of the extracts
increases with increase in their concentration (Figure 5).
3.2. In Vivo Analysis. The eﬀect on the biomarkers of
oxidative stress was studied by evaluating the content of
biomarkers GSH and MDA in mice erythrocytes.Evidence-Based Complementary and Alternative Medicine 5
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Figure 1: Concentration-dependent total phenolic estimation of
ethanolic and aqueous extract of Moringa oleifera fruit and leaf
(MLW: Moringa leaf aqueous extract, MLE: Moringa leaf ethanol
extract, MFW: Moringa fruit (pod) aqueous extract, MFE: Moringa
fruit (pod) ethanol extract; values are mean ± SD of three
independent experiments in replicates at each concentration and
estimated in terms of gallic acid equivalence).
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Figure 2: Concentration-dependent reducing power of ethanolic
and aqueous extract of Moringa oleifera fruit and leaf (MLW:
Moringa leaf aqueous extract, MLE: Moringa leaf ethanol extract,
MFW: Moringa fruit (pod) aqueous extract, MFE: Moringa fruit
(pod) ethanol extract; values are mean ± SD of three independent
experiments in replicates at each concentration).
3.2.1. Reduced Glutathione and Malondialdehyde Concentra-
tion. Figure 6 shows the dose-responsive eﬀect of alcoholic
and aqueous extract of Moringa fruit and leaves on GSH
content. Maximum enhancement of GSH was observed
in mice erythrocytes treated with the aqueous extract of
Moringa leaves (MLW). This rise is consistent with the
increase in the dose of the extract. In our study, the
signiﬁcant increase of GSH content with the administration
of aqueous extract of leaves in dose-dependent manner
shows higher antioxidant capacity, compared to fruit extract
(two tailed t-test, P = 0.0004). Similarly, the dose-responsive
eﬀect on lipid peroxidation was also observed (Figure 7).
The basal value of MDA content was maintained in case of
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Figure 3: Concentration-dependent free radical scavenging
(DPPH) activity of ethanolic and aqueous extract of Moringa
oleifera fruit and leaf (MLW: Moringa leaf aqueous extract, MLE:
Moringa leaf ethanol extract, MFW: Moringa fruit (pod) aqueous
extract, MFE: Moringa fruit (pod) ethanol extract; values are
mean ± SD of three independent experiments in replicates at each
concentration).
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Figure 4: Concentration-dependent ferric reducing antioxidant
power of ethanolic and aqueous extract of Moringa oleifera fruit
and leaf (MLW: Moringa leaf aqueous extract, MLE: Moringa leaf
ethanol extract, MFW: Moringa fruit (pod) aqueous extract, MFE:
Moringa fruit (pod) ethanol extract; values are mean ± SD of three
independent experiments in replicates at each concentration and
expressed in terms of ferrous sulphate equivalence).
the aqueous extract of moringa leaf (MLW), compared to
ethanolic extract where a rise in MDA content was recorded.
The aqueous fruit extract (MFW) was able to lower down
the MDA level signiﬁcantly (P = 0.0121 for unpaired t-test)
at 0.1mg/kg b/w which again rose to normal level at higher
concentrations.
To assess the correlation with antioxidative properties,
total phenolic content, reducing power, ferric reducing,
free radical scavenging, and total antioxidant capacity of
the extracts were determined in serum samples of mice
(Figures 8–12).6 Evidence-Based Complementary and Alternative Medicine
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Figure 5: Concentration-dependent total antioxidant capacity of
ethanolic and aqueous extract of Moringa oleifera fruit and leaf
(MLW: Moringa leaf aqueous extract, MLE: Moringa leaf ethanol
extract, MFW: Moringa fruit (pod) aqueous extract, MFE: Moringa
fruit (pod) ethanol extract; values are mean ± SD of three
independent experiments in replicates at each concentration and
determined in terms of ascorbic acid equivalence).
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Figure 6: Eﬀect of ethanolic and aqueous extract of Moringa
oleifera fruit and leaf on reduced glutathione concentration of mice
erythrocytes (MLW: Moringa leaf aqueous extract, MLE: Moringa
leaf ethanol extract, MFW: Moringa fruit (pod) aqueous extract,
MFE: Moringa fruit (pod) ethanol extract; values are mean ± SD of
erythrocytes GSH content from replicates of six mice in each group
at each dose).
3.2.2. Total Phenolic Content, Reducing Power, DPPH, FRAP,
and Total Antioxidant Capacity. In the in vivo analysis of
the extracts, the serum sample of mice administered with
extract MFE showed the highest content of total phenolics at
the dose of 10mg/kg b/w congruent to the ethanolic extract
of leaves (MLE; Figure 8). Increasing the dose showed no
signiﬁcant changes in the total phenolic content. The in vivo
analysis of reducing power for the serum of mice adminis-
tered with diﬀerent doses of Moringa oleifera leaves and fruit
extracts in dose-dependent manner showed conformity with
that of in vitro analysis (MFE > MLE > MFW∼MLW;
Figure 9). Similarly, DPPH scavenging assay showed the
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Figure7:EﬀectofethanolicandaqueousextractofMoringaoleifera
fruit and leaf on malondialdehyde content of mice erythrocytes
(MLW: Moringa leaf aqueous extract, MLE: Moringa leaf ethanol
extract, MFW: Moringa fruit (pod) aqueous extract, MFE: Moringa
fruit (pod) ethanol extract; values are mean ± SD of erythrocytes
MDA content taken from replicates of six mice in each group at
each dose).
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Figure 8: Dose-dependent total phenolic estimation of ethanolic
and aqueous extract of Moringa oleifera fruit and leaf in mice serum
(MLW: Moringa leaf aqueous extract, MLE: Moringa leaf ethanol
extract, MFW: Moringa fruit (pod) aqueous extract, MFE: Moringa
fruit (pod) ethanol extract; values are mean ± SD of serum taken
from replicates of six mice in each group at each dose and estimated
in terms of gallic acid equivalence).
same pattern (MFE∼MFW > MLE∼MLW) to that of in vitro
analysis but the scavenging potential was observed to a dose
of 1mg/kg b/w after which, the eﬀect was almost constant
(Figure 10). In dose-dependent studies, the serum from mice
groups administered with ethanolic extracts showed more
ferric reducing antioxidant power than the serum of mice
administered with aqueous extracts. The trend observed was
MFE > MLE > MLW > MFW (Figure 11), whereas MLW
showed highest antioxidant capacity (Figure 12). A linear
correlationbetween DPPHradicalscavengingactivity,FRAP,Evidence-Based Complementary and Alternative Medicine 7
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Figure 9: Dose-dependent reducing power estimation of ethanolic
and aqueous extract of Moringa oleifera fruit and leaf in mice serum
(MLW: Moringa leaf aqueous extract, MLE: Moringa leaf ethanol
extract, MFW: Moringa fruit (pod) aqueous extract, MFE: Moringa
fruit (pod) ethanol extract; values are mean ± SD of serum taken
from replicates of six mice in each group at each dose).
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Figure10:Dose-dependentfreeradicalscavenging(DPPH)activity
of ethanolic andaqueous extract of Moringaoleiferafruit andleafin
mice serum (MLW: Moringa leaf aqueous extract, MLE: Moringa
leaf ethanol extract, MFW: Moringa fruit (pod) aqueous extract,
MFE: Moringa fruit (pod) ethanol extract; Values are mean ± SD
of serum taken from replicates of six mice in each group at each
dose).
and polyphenolic content (P<0.0001) of the extract has
been observed.
3.2.3. Observational, Haematological, Biochemical, and Gross
Pathological Analysis. To study the toxicity of ethanolic and
aqueous extract of M. oleifera leaves and fruit, animals
were challenged with diﬀerent doses and their safety proﬁles
were determined by evaluating haematological, biochemical,
and pathological parameters. The body weights recorded
from all the animals on the seventh day after experiment
were within 27 ± 1g and showed no signiﬁcant alterations
(Figure 13). The biochemical parameters ALKP, SGPT, and
SGOT showed nonsigniﬁcant changes, even increase in
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Figure 11: Dose-dependent ferric reducing antioxidant power of
ethanolic and aqueous extract of Moringa oleifera fruit and leaf in
mice serum (MLW: Moringa leaf aqueous extract, MLE: Moringa
leaf ethanol extract, MFW: Moringa fruit (pod) aqueous extract,
MFE: Moringa fruit (pod) ethanol extract; values are mean ± SD
of serum taken from replicates of six mice in each group at each
dose and expressed in terms of ferrous sulphate equivalence).
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Figure 12: Dose-dependent total antioxidant capacity of ethanolic
and aqueous extract of Moringa oleifera fruit and leaf in mice
serum (MLW: Moringa leaf aqueous extract, MLE: Moringa leaf
ethanol extract, MFW: Moringa fruit (pod) aqueous extract, MFE:
Moringa fruit(pod)ethanol extract;values aremean ±SD of serum
t a k e nf r o mr e p l i c a t e so fs i xm i c ei ne a c hg r o u pa te a c hd o s ea n d
determined in terms of ascorbic acid equivalence).
the dose of the extract was well tolerated and nontoxic
(Figures 14, 15,a n d16). The haematological parameters
RBC, WBC, Hb were also analyzed (Figures 17, 18,a n d19).
Except total RBC count in MLE, no change was observed
among the diﬀerent extracts in the haematological studies.
Even the value of RBC count is similar to that of vehicle
control studied with same extract.
4. Discussion
For hundreds of years, traditional healers have prescribed
diﬀerent parts of M. oleifera for treatment of skin diseases,
respiratory illnesses, ear and dental infections, hypertension,8 Evidence-Based Complementary and Alternative Medicine
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Figure 13: Dose-dependent eﬀect of ethanolic and aqueous extract
of Moringa oleifera fruit and leaf on body weight of mice (MLW:
Moringa leaf aqueous extract, MLE: Moringa leaf ethanol extract,
MFW: Moringa fruit (pod) aqueous extract, MFE: Moringa fruit
(pod) ethanol extract; values are mean ± SD of serum taken from
replicates of six mice in each group at each dose).
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Figure 14: Dose-dependent eﬀect of ethanolic and aqueous extract
of Moringa oleifera fruit and leaf on SGOT activity of mice (MLW:
Moringa leaf aqueous extract, MLE: Moringa leaf ethanol extract,
MFW: Moringa fruit (pod) aqueous extract, MFE: Moringa fruit
(pod) ethanol extract; values are mean ± SD of serum taken from
replicates of six mice in each group at each dose).
diabetes, cancer treatment, and water puriﬁcation, and they
have promoted its use as a nutrient dense food source
[6, 10, 12]. Herein, we report a comparative in vitro and
in vivo analysis of the eﬀect of aqueous and ethanolic
extracts of Moringa leaf and fruit on the markers of oxidative
stress. Biomarkers of oxidative stress reﬂect environmental
pro-oxidant and antioxidant ratio and also serve as a
surrogate measure of a disease process. The protective
eﬀects of aqueous and ethanolic extract of Moringa leaf and
fruit on erythrocyte GSH and MDA concentration may be
attributed to the presence of phytoconstituents (polyphe-
nols, tannins, anthocyanin, glycosides, thiocarbamates) that
scavenge free radicals, activate the antioxidant enzymes, and
inhibit oxidases [55, 56]. In present study, we studied both
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Figure 15: Dose-dependent eﬀect of ethanolic and aqueous extract
of Moringa oleifera fruit and leaf on SGPT activity of mice (MLW:
Moringa leaf aqueous extract, MLE: Moringa leaf ethanol extract,
MFW: Moringa fruit (pod) aqueous extract, MFE: Moringa fruit
(pod) ethanol extract; values are mean ± SD of serum taken from
replicates of six mice in each group at each dose).
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Figure 16: Dose-dependent eﬀect of ethanolic and aqueous extract
of Moringa oleifera fruit and leaf on ALKP activity of mice (MLW:
Moringa leaf aqueous extract, MLE: Moringa leaf ethanol extract,
MFW: Moringa fruit (pod) aqueous extract, MFE: Moringa fruit
(pod) ethanol extract; values are mean ± SD of serum taken from
replicates of six mice in each group at each dose).
concentration- and dose-dependent analysis by estimating
GSH and MDA concentration in vitro as well as in vivo.
Glutathione (GSH) acts as an antioxidant both intra-
cellularly and extracellulary, and it is a major nonpro-
tein sulfhydryl compound, with many biological functions,
including maintenance of membrane protein-SH groups in
the reduced form, the oxidation of which can otherwise
cause altered cellular structure and function [57, 58].
Membrane-SHgroupoxidativedamagemaybeanimportant
molecular mechanism inducing changes in the membrane
microelasticity or whole cell deformability of erythrocytes
under conditions of physiological and pathological oxidative
stress.TheaqueousextractofMoringa leavescontainscertain
nonphenolic, biologically active components such as sele-
nium,thiocarbamates,glucosinolates,itshydrolysisproductsEvidence-Based Complementary and Alternative Medicine 9
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Figure 17: Dose-dependent eﬀect of ethanolic and aqueous extract
of Moringa oleifera fruit and leaf on WBC count of mice blood
(MLW: Moringa leaf aqueous extract, MLE: Moringa leaf ethanol
extract, MFW: Moringa fruit (pod) aqueous extract, MFE: Moringa
fruit (pod) ethanol extract; values are mean ± SD of serum taken
from replicates of six mice in each group at each dose).
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Figure 18: Dose-dependent eﬀect of ethanolic and aqueous extract
of Moringa oleifera fruit and leaf on RBC count of mice blood
(MLW: Moringa leaf aqueous extract, MLE: Moringa leaf ethanol
extract, MFW: Moringa fruit (pod) aqueous extract, MFE: Moringa
fruit (pod) ethanol extract; values are mean ± SD of serum taken
from replicates of six mice in each group at each dose).
as glucoraphanin, isothiocyanate sulforaphane, nitriles [22,
23],inadditiontothephenolics,whichcouldserveasantiox-
idants and may eﬀectively scavenge various reactive oxygen
species/free radicals under in vivo conditions. The ethanolic
extract of the leaves, rich in phenolic components, showed
increased GSH content at lower dose, increasing the dose
further decreases the GSH content, an eﬀect which may be
due to cytotoxicity of high phenolic content. The erythrocyte
membrane is prone to lipid peroxidation under oxidative
stress that leads to the formation of MDA, a biomarker
used for studying the oxidation of lipids under diﬀerent
conditions [59, 60]. Like GSH content, a similar pattern
was observed for MDA, aqueous extract of Moringa leaves
maintained the normal level of erythrocyte MDA, suggesting
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Figure 19: Dose-dependent eﬀect of ethanolic and aqueous extract
of Moringa oleifera fruit and leaf on haemoglobin level of mice
blood (MLW: Moringa leaf aqueous extract, MLE: Moringa leaf
ethanol extract, MFW: Moringa fruit (pod) aqueous extract, MFE:
Moringa fruit(pod)ethanol extract;values aremean ±SD of serum
taken from replicates of six mice in each group at each dose).
that the extract may have a mixture of biomolecules with
hydroxyl groups that prevent the abstraction of hydrogen
atom from the double bond of lipid bilayer thereby avoiding
the damage of lipid membrane. An inhibition of lipid
peroxidation (LPO) was observed in a dose-dependent
manner, but it was not very signiﬁcant. Our results are
concomitantwithourpreviousreportfortheinvitroanalysis
of the plant extracts [44], wherein the normal level of
malondialdehyde content of the erythrocyte was maintained.
But aqueous extract of fruit showed a signiﬁcant reduction
(P = 0.0121forunpairedt-test),inmalondialdehydecontent
at dose of 0.1mg/kgb/w. As previously reported [13, 61],
the reducing power of bioactive compounds was associated
with antioxidant activity. Thus, for the explication of the
relationship between antioxidant eﬀect and reducing power
of the phenolics, the determination of reducing power was a
necessity. We did a comparative analysis for the antioxidant
properties of aqueous and ethanolic extracts of Moringa
leaf and fruit and assess their capacity to reduce potassium
ferricyanide and scavenge free radicals both in vitro and
in vivo. The total phenolic content of the Moringa leaf
and fruit extracts was determined in terms of gallic acid
equivalence. Our observations are in agreement with the
previous ﬁndings of Siddhuraju and Becker [13], where
high content of phenolics in the ethanolic extract of leaves
compared to aqueous extract was reported. In addition,
our ﬁndings on comparative analysis depict higher amount
of phenolics in fruit (pod). In vivo analysis with serum
showed a signiﬁcant pattern (P = 0.0053) similar to that
of in vitro studies. The reducing power of all the extracts
showed a concentration- and dose-dependent increase in
absorbance (P<0.0001); however, when compared, the
fruit extract proved to be better in both water and ethanol
(P<0.0001). The aqueous extract appeared to be less
eﬀectivecomparedtoethanolicextract.Ingeneral,thehigher
polyphenols extraction yield corresponds with the higher10 Evidence-Based Complementary and Alternative Medicine
antioxidant activity, probably due to the combined action
of the substances in variable concentrations and their high
hydrogen atom donating abilities. Our ﬁndings are well
correlated with the amount of phenolic constituents present
in the respective extract. The phenolics present in Moringa
fruit extract are able to terminate the radical chain reaction
by converting free radicals to more stable products. The
FRAP analysis shows aqueous extract of Moringa fruit was
themosteﬀective(P<0.0001). Similarly, alinearcorrelation
between DPPH radical scavenging activity (P<0.0001) and
polyphenolic extract has been reported with variability in
concentration and doses for the leaf extract [13].
The total antioxidant capacity was analysed in terms
of ascorbic acid and was best observed at a concentration
of 10mg/kgb/w dose in leaf aqueous extract with signif-
icant P value of 0.05 which decreases on further increase
in the dose. The antioxidant capacity of the ethanolic
extract of fruit showed an increase with increasing dose
from 0.01mg/kgb/w to 100mg/kgb/w (P<0.05), which
may be attributed to the high content of ﬂavonoids such
as kaempferol and other polyphenols [62]. Other com-
pounds that might contribute to total antioxidant capacity
arecarotenoidsandcinnamicacidderivatives[63].Although
total antioxidant capacity measurement does not represent
the sum of activities of single antioxidants, it can be of
clinical use, because it is an easy and less time consuming
procedure.
To evaluate the toxicity of the extracts, doses of
various concentrations ranging from 0.01mg/kgb/w to
100mg/kgb/w were analysed for toxicity. No mortality
or morbidity was observed throughout the experimental
period. Nonsigniﬁcant changes were observed in absolute
weight and similarly no changes were observed in vital
organ weight measurement both in absolute and relative
terms. Haematological parameters showed nonsigniﬁcant
changes except in RBC count at administration of ethanolic
extract of Moringa leaves, but this was comparable and
nonsigniﬁcant relative to the control system. Most of the
serum biochemical parameters as SGPT, SGOT, and ALKP
exhibited nonsigniﬁcant changes. The extracts were well
tolerated till dose of 100mg/kg b/w, with no toxicity.
Recently, we have showed concentration-dependent
hydroxyl radical scavenging ability of Moringa oleifera fruit
and leaf extracts in deoxy ribose degradation assay [64]
and our present ﬁndings may in part not only suggest the
use of Moringa fruit and leaves as a supplementary/dietary
antioxidant in nutraceutical and/or cosmoceutical, but also
improve the ethnopharmacological knowledge of Moringa
plant, which paves the way for use of fruit and leaves
as an economically viable source of natural and potent
antioxidant.
5. Conclusion
Based on our observations, the ethanolic and aqueous
extract of Moringa fruit and leaf signiﬁcantly maintains the
basal levels of GSH and MDA content in a concentration-
and dose-dependent manner. The ethanolic extract of fruit
showed highest phenolic content along with strong reducing
power and free radical scavenging capacity. Safety evaluation
studies showed that ethanolic and aqueous extract of both
fruit and leaf was well tolerated by experimental animals. A
highpositivecorrelationwasobservedamongtheinvitroand
in vivo assays for antioxidative properties. In addition, our
results support the potent antioxidant activity of aqueous
and ethanolic extract of Moringa which adds one more
positive attribute to its known pharmacological proper-
ties and hence its use in traditional system of medicine.
Further investigations on isolation, characterization, and
identiﬁcation of active phytoconstituents responsible for the
protection of oxidative stress and antioxidant activity are
warranted for future work.
Abbreviations
ALKP: Alkaline Phosphatase
DMSO: Dimethyl sulfoxide
DPPH: 2, 2-diphenyl-2-picrylhydrazyl
DTNB: 5, 5 -Dithiobis 2-nitro benzoic acid
FRAP: Ferric reducing antioxidant power
GAE: Gallic acid equivalent
AAE: Ascorbic acid equivalent GSH, glutathione
GSH: Glutathione
MDA: Malondialdehyde
MFW: Moringa fruit (pod) aqueous extract
MFE: Moringa fruit (pod) ethanol extract
MLW: Moringa leaf aqueous extract
MLE: Moringa leaf ethanol extract
RP: Reducing power
Hb: Hemoglobin
RBC: Red blood corpuscles
WBC: White blood corpuscles
SGPT: Serum glutamic pyruvic transaminase
SGOT: Serum glutamic oxaloacetic transaminase
TAC: Total antioxidant capacity
t-BHP: Tertiary-Butyl hydroperoxide
TBA: Thiobarbituric acid
TCA: Trichloroacetic acid
TPC: Total phenolic content
TPTZ: Tripyridyl-s-triazine.
Acknowledgments
The authors are thankful to Director, CIMAP (CSIR), for
encouragementandprovidingnecessaryfacilities.S.Luqman
acknowledges the ﬁnancial support from Department of
Science and Technology (DST), New Delhi, for the ﬁnancial
support under DST Fast Track Scheme for Young Scientist.
References
[1] M.A.Somali,M.A.Bajneid,andS.S.Al-Fhaimani,“Chemical
composition and characteristics of Moringa peregrina seeds
and seeds oil,” Journal of the American Oil Chemists’ Society,
vol. 61, no. 1, pp. 85–86, 1984.
[2] M. H. S. Mughal, G. Ali, P. S. Srivastava, and M. Iqbal,
“Improvement of drumstick(Moringapterygosperma Gaertn.)Evidence-Based Complementary and Alternative Medicine 11
A unique source of food and medicine through tissue culture,”
Hamdard Medicus, vol. 42, pp. 37–42, 1999.
[3] J. F. Morton, “The horseradish tree, Moringa pterygosperma
(Moringaceae)-A boon to Arid Lands?” Economic Botany, vol.
45, no. 3, pp. 318–333, 1991.
[4] J. D. Souza and A. R. Kulkarni, “Comparative studies on
nutritive values of tender foliage of seedlings and mature
plants of Moringa oleifera Lam,” Journal of Economic and
Taxonomic Botany, vol. 17, pp. 479–785, 1993.
[5] M. C. Palada, “Moringa (Moringa oleifera Lam.): a versatile
treecropwithhorticulturalpotentialinthesubtropicalUnited
States,” HortScience, vol. 31, no. 5, pp. 794–797, 1996.
[6] L. J. Fuglie, The Miracle Tree: Moringa oleifera: Natural Nutri-
tion for the Tropics, Church World Service, Dakar, Senegal,
1999.
[ 7 ] C .J .Di ll a r da n dJ .B ru c eG e rm a n ,“ P h yt oc h e m i c a l s :n u trac e u -
ticals and human health,” Journal of the Science of Food and
Agriculture, vol. 80, no. 12, pp. 1744–1756, 2000.
[8] F. Anwar and M. I. Bhanger, “Analytical characterization
of Moringa oleifera seed oil grown in temperate regions of
Pakistan,” Journal of Agricultural and Food Chemistry, vol. 51,
no. 22, pp. 6558–6563, 2003.
[9] F. Anwar, M. Ashraf, and M. I. Bhanger, “Interprovenance
variation in the composition of Moringa oleifera oilseeds
from Pakistan,” JAOCS, Journal of the American Oil Chemists’
Society, vol. 82, no. 1, pp. 45–51, 2005.
[10] F. Anwar, S. Latif, M. Ashraf, and A. H. Gilani, “Moringa
oleifera: a food plant with multiple medicinal uses,” Phytother-
apy Research, vol. 21, no. 1, pp. 17–25, 2007.
[11] M. D. Thurber and J. W. Fahey, “Adoption of Moringa
oleifera to combat under-nutrition viewed through the lens
of the “Diﬀusion of innovations” theory,” Ecology of Food and
Nutrition, vol. 48, no. 3, pp. 212–225, 2009.
[12] J. W. Fahey, “Moringa oleifera: a Review of the medical
evidence for its nutritional, therapeutic, and prophylactic
properties. Part 1,” Trees for Life Journal, vol. 1, aticle 5, 2005.
[13] P. Siddhuraju and K. Becker, “Antioxidant properties of
various solvent extracts of total phenolic constituents from
threediﬀerentagroclimaticoriginsofdrumsticktree(Moringa
oleifera Lam.) leaves,” Journal of Agricultural and Food Chem-
istry, vol. 51, no. 8, pp. 2144–2155, 2003.
[ 1 4 ]M .C .P .E s t r e l l a ,J .B .V .M a n t a r i n g ,a n dG .Z .D a v i d ,
“A double blind randomised controlled trial on the use
of malunggay (Moringa oleifera) for augmentation of the
volume of breastmilk among non-nursing mothers of preterm
infants,” The Philippine Journal of Pediatrics, vol. 49, pp. 3–6,
2000.
[15] S. K. Pal, P. K. Mukherjee, and B. P. Saha, “Studies on the
antiulcer activity of Moringa oleifera leaf extract on gastric
ulcer models in rats,” Phytotherapy Research, vol. 9, no. 6, pp.
463–465, 1995.
[16] S. K. Pal, P. K. Mukherjee, K. Saha, M. Pal, and B. P. Saha,
“Antimicrobial action of the leaf extract of Moringa oleifera
Lam.,” Ancient Science of Life, vol. 14, pp. 197–199, 1995.
[17] P. Tahiliani and A. Kar, “Role of Moringa oleifera leaf extract
in the regulation of thyroid hormone status in adult male and
female rats,” Pharmacological Research, vol. 41, no. 3, pp. 319–
323, 2000.
[18] M. U. Dahot, “Vitamin contents of ﬂowers and seeds of
Moringa oleifera,” Pakistan Journal of Biochemistry, vol. 21, pp.
1–24, 1988.
[19] A. Caceres and S. Lopez, “Pharmacological properties of
Moringa oleifera.3 .E ﬀect of seed extracts in the treatment of
experimental pyodermia,” Fitoterapia, vol. 62, no. 5, pp. 449–
450, 1991.
[20] A. Caceres, A. Saravia, S. Rizzo, L. Zabala, E. De Leon, and
F. Nave, “Pharmacologic properties of Moringa oleifera.2 :
screening for antispasmodic, antiinﬂammatory and diuretic
activity,”JournalofEthnopharmacology,vol.36,no.3,pp.233–
237, 1992.
[21] A. H. Gilani, K. Aftab, F. Shaheen et al., “Antispasmodic
activity of active principle from Moringa oleifera,” in Natural
DrugsandtheDigestiveTract,F.CapassoandN.Mascolo,Eds.,
pp. 60–63, EMSI, Rome, Italy, 1992.
[22] S. Faizi, B. S. Siddiqui, R. Saleem, S. Siddiqui, K. Aftab, and A.
U. H. Gilani, “Novel hypotensive agents, niazimin A, niazimin
B, niazicin A and niazicin B from Moringa oleifera: isolation of
ﬁrst naturally occurring carbamates,” Journal of the Chemical
Society, Perkin Transactions, no. 20, pp. 3035–3040, 1994.
[23] S. Faizi, B. S. Siddiqui, R. Saleem, S. Siddiqui, K. Aftab, and
A. U. H. Gilani, “Isolation and structure elucidation of new
nitrile and mustard oil glycosides from Moringa oleifera and
theireﬀectonbloodpressure,”JournalofNaturalProducts,vol.
57, no. 9, pp. 1256–1261, 1994.
[24] S. Faizi, B. S. Siddiqui, R. Saleem, K. Aftab, F. Shaheen, and
A. U. H. Gilani, “Hypotensive constituents from the pods of
Moringa oleifera,” Planta Medica, vol. 64, no. 3, pp. 225–228,
1998.
[25] S. Faizi, B. S. Siddiqui, R. Saleem, S. Siddiqui, K. Aftab, and A.
H. Gilani, “Fully acetylated carbamate and hypotensive thio-
carbamate glycosides from Moringa oleifera,” Phytochemistry,
vol. 38, no. 4, pp. 957–963, 1995.
[26] S. Ghasi, E. Nwobodo, and J. O. Oﬁli, “Hypocholesterolemic
eﬀects of crude extract of leaf of Moringa oleifera Lam in high-
fat diet fed wistar rats,” Journal of Ethnopharmacology, vol. 69,
no. 1, pp. 21–25, 2000.
[27] S. Y. Dangi, C. I. Jolly, and S. Narayanan, “Antihypertensive
activity of the total alkaloids from the leaves of Moringa
oleifera,” Pharmaceutical Biology, vol. 40, no. 2, pp. 144–148,
2002.
[28] L. K. Mehta, R. Balaraman, A. H. Amin, P. A. Bafna, and O.
D. Gulati, “Eﬀect of fruits of Moringa oleifera on the lipid
proﬁle of normal and hypercholesterolaemic rabbits,” Journal
of Ethnopharmacology, vol. 86, no. 2-3, pp. 191–195, 2003.
[29] A.H.Gilani,K.Aftab,A.Suriaetal.,“Pharmacologicalstudies
on hypotensive and spasmolytic activities of pure compounds
fromMoringaoleifera,” PhytotherapyResearch,v ol.8,no .2,pp .
87–91, 1994.
[30] B. R. Das, P. A. Kurup, and P. L. Rao, “Antibiotic principle
from Moringa pterygosperma. VII. Antibacterial activity and
chemical structure of compounds related to pterygospermin,”
The Indian Journal of Medical Research, vol. 45, no. 2, pp. 191–
196, 1957.
[31] U. Eilert, B. Wolters, and A. Nahrstedt, “The antibiotic prin-
ciple of seeds of Moringa oleifera and Moringa Stenopetala,”
Planta Medica, vol. 42, no. 1, pp. 55–61, 1981.
[32] A. Caceres, O. Cabrera, O. Morales, P. Mollinedo, and P.
Mendia, “Pharmacological properties of Moringa oleifera.1 :
preliminary screening for antimicrobial activity,” Journal of
Ethnopharmacology, vol. 33, no. 3, pp. 213–216, 1991.
[33] F. Nikkon, Z. A. Saud, M. H. Rehman, and M. E. Haque, “In
vitro antimicrobial activity of the compound isolated from
chloroform extract of Moringa oleifera Lam.,” Pakistan Journal
of Biological Sciences, vol. 22, pp. 1888–1890, 2003.
[34] A. Murakami, Y. Kitazono, S. Jiwajinda, K. Koshimizu, and
H. Ohigashi, “Niaziminin, a thiocarbamate from the leaves
of Moringa oleifera, holds a strict structural requirement for12 Evidence-Based Complementary and Alternative Medicine
inhibition of tumor-promoter-induced epstein- barr virus
activation,” Planta Medica, vol. 64, no. 4, pp. 319–323, 1998.
[35] A. P. Guevara, C. Vargas, H. Sakurai et al., “An antitumor
promoter from Moringa oleifera Lam,” Mutation Research, vol.
440, no. 2, pp. 181–188, 1999.
[36] R. Bharali, J. Tabassum, and M. R. Azad, “Chemomodu-
latory eﬀect of Moringa oleifera, Lam, on hepatic carcino-
gen metabolising enzymes, antioxidant parameters and skin
papillomagenesis in mice,” Asian Paciﬁc Journal of Cancer
Prevention, vol. 4, no. 2, pp. 131–139, 2003.
[37] A. H. Gilani, K. H. Janbaz, and B. H. Shah, “Quercetin
exhibits hepatoprotective activity in rats,” Biochemical Society
Transactions, vol. 25, article 85, 1997.
[38] A. Ndabigengesere, K. Subba Narasiah, and B. G. Talbot,
“Active agents and mechanism of coagulation of turbid waters
usingMoringaoleifera,” WaterResearch,vol.29,no.2,pp.703–
710, 1995.
[39] K. A. Ghebremichael, K. R. Gunaratna, H. Henriksson, H.
Brumer, and G. Dalhammar, “A simple puriﬁcation and
activity assay of the coagulant protein from Moringa oleifera
seed,” Water Research, vol. 39, no. 11, pp. 2338–2344, 2005.
[40] J. T. A. Oliveira, S. B. Silveira, I. M. Vasconcelos, B. S. Cavada,
and R. A. Moreira, “Compositional and nutritional attributes
of seeds from the multiple purpose tree Moringa oleifera
Lamarck,” Journal of the Science of Food and Agriculture, vol.
79, no. 6, pp. 815–820, 1999.
[41] The Wealth of India (A Dictionary of Indian Raw Materials
and Industrial Products), Raw Materials, Council of Scientiﬁc
and Industrial Research, New Delhi, India, 1960.
[42] S. Luqman and S. I. Rizvi, “Protection of lipid peroxida-
tion and carbonyl formation in proteins by capsaicin in
human erythrocytes subjected to oxidative stress,” Phytother-
apy Research, vol. 20, no. 4, pp. 303–306, 2006.
[43] S. I. Rizvi and S. Luqman, “Anti-oxidative property of
capsaicin,” Medicinal Chemistry Research, vol. 11, no. 5, pp.
301–307, 2002.
[ 4 4 ] S .L u q m a n ,S .K a u s h i k ,S .S r i v a s t a v ae ta l . ,“ P r o t e c t i v ee ﬀect of
medicinal plant extracts on biomarkers of oxidative stress in
erythrocytes,” Pharmaceutical Biology, vol. 47, no. 6, pp. 483–
490, 2009.
[45] V. L. Singleton and J. A. Rossi, “Colorimetry of total pheno-
lics with phosphomolybdic-phosphotungstic acid reagents,”
American Journal of Enology and Viticulture, vol. 16, pp. 144–
158, 1965.
[ 4 6 ] S .L u q m a n ,R .K u m a r ,S .K a u s h i k ,S .S ri v a s t a v a ,M .P .D a r o k a r ,
and S. P. S. Khanuja, “Antioxidant potential of the root of
Vetiveria zizanioides (L.) Nash,” Indian Journal of Biochemistry
and Biophysics, vol. 46, no. 1, pp. 122–125, 2009.
[47] G. C. Yen and H. Y. Chen, “Antioxidant activity of various
tea extracts in relation to their antimutagenicity,” Journal of
Agricultural and Food Chemistry, vol. 43, no. 1, pp. 27–32,
1995.
[48] I. F. F. Benzie and J. J. Strain, “The ferric reducing ability of
plasma (FRAP) as a measure of ’antioxidant power’: the FRAP
assay,”AnalyticalBiochemistry,vol.239,no.1,pp.70–76,1996.
[49] Y. C. Chung, C. T. Chang, W. W. Chao, C. F. Lin, and S. T.
Chou, “Antioxidative activity and safety of the 50% ethanolic
extract from red bean fermented by Bacillus subtilis IMR-
NK1,” Journal of Agricultural and Food Chemistry, vol. 50, no.
8, pp. 2454–2458, 2002.
[50] P. Prieto, M. Pineda, and M. Aguilar, “Spectrophotometric
quantitation of antioxidant capacity through the formation of
a phosphomolybdenum complex: speciﬁc application to the
determination of vitamin E,” Analytical Biochemistry, vol. 269,
no. 2, pp. 337–341, 1999.
[ 5 1 ]E .B e u t l e r ,O .D u r o n ,a n dB .M .K e l l y ,“ I m p r o v e dm e t h o d
for the determination of blood glutathione,” The Journal of
Laboratory and Clinical Medicine, vol. 61, pp. 882–888, 1963.
[52] H. Esterbauer and K. H. Cheeseman, “Determination of
aldehydic lipid peroxidation products: malonaldehyde and 4-
hydroxynonenal,” Methods in Enzymology, vol. 186, pp. 407–
421, 1990.
[53] J. Joshua Allan, A. Damodaran, N. S. Deshmukh, K. S.
Goudar, and A. Amit, “Safety evaluation of a standardized
phytochemical composition extracted from Bacopa monnieri
in Sprague-Dawley rats,” Food and Chemical Toxicology, vol.
45, pp. 1928–1937, 2007.
[54] D. Chanda, K. Shanker, A. Pal et al., “Safety evaluation of
trikatu, a generic ayurvedic medicine in Charles Foster rats,”
Journal of Toxicological Sciences, vol. 34, no. 1, pp. 99–108,
2009.
[55] J. Y.Liu, C.C.Chen, W. H.Wang, J. D.Hsu, M.Y.Yang, and C.
J .W a n g ,“ T h ep r o t e c t i v ee ﬀects of Hibiscus sabdariﬀa extract
on CCl 4-induced liver ﬁbrosis in rats,” Food and Chemical
Toxicology, vol. 44, no. 3, pp. 336–343, 2006.
[ 5 6 ]A .A m i na n dA .A .H a m z a ,“ H e p a t o p r o t e c t i v ee ﬀects of
Hibiscus, Rosmarinus and Salvia on azathioprine-induced
toxicity in rats,” Life Sciences, vol. 77, no. 3, pp. 266–278, 2005.
[57] J.Reglinski,S.Hoey,W.E.Smith,andR.D.Sturrock,“Cellular
response to oxidative stress at sulfhydryl group receptor sites
on the erythrocyte membrane,” The Journal of Biological
Chemistry, vol. 263, no. 25, pp. 12360–12366, 1988.
[58] P. Di Simplicio, E. Lupis, and R. Rossi, “Diﬀerent mecha-
nisms of formation of glutathione-protein mixed disulﬁdes
of diamide and tert-butyl hydroperoxide in rat blood,”
Biochimica et Biophysica Acta, vol. 1289, no. 2, pp. 252–260,
1996.
[59] D. Konukoglu, T. Akc ¸ay, and T. Erdemm, “Susceptibility of
erythrocyte lipids to oxidation and erythrocyte antioxidant
status in myocardial infarction,” Clinical Biochemistry, vol. 31,
no. 8, pp. 667–671, 1998.
[60] A. L´ opez-Revuelta, J. I. S´ anchez-Gallego, A. Hern´ andez-
Hern´ andez, J. S´ anchez-Yag¨ ue, and M. Llanillo, “Increase in
vulnerability to oxidative damage in cholesterol-modiﬁed
erythrocytes exposed to t-BuOOH,” Biochimica et Biophysica
Acta, vol. 1734, no. 1, pp. 74–85, 2005.
[61] G. C. Yen, “Relationship between antioxidant activity and
maturity of peanut hulls,” Journal of Agricultural and Food
Chemistry, vol. 41, no. 1, pp. 67–70, 1993.
[62] R. N. Bennett, F. A. Mellon, N. Foidl et al., “Proﬁling glucosi-
nolates and phenolics in vegetative and reproductive tissues of
the multi-purpose trees Moringa oleifera L. (Horseradish tree)
and Moringa stenopetala L,” Journal of Agricultural and Food
Chemistry, vol. 51, no. 12, pp. 3546–3553, 2003.
[ 6 3 ]M .S .T a g a ,E .E .M i l l e r ,a n dD .E .P r a t t ,“ C h i as e e d sa sa
source of natural lipid antioxidants,” Journal of the American
Oil Chemists’ Society, vol. 61, no. 5, pp. 928–931, 1984.
[64] S. Luqman and R. Kumar, “Attenuation of hydroxyl radical
formation by extracted constituent of Moringa oleifera lam.,”
Current Chemical Biology, vol. 5, no. 3, pp. 213–218, 2011.